Why do we need to identify and treat women with depression who experience during pregnancy? We have long known that postpartum depression can negatively affect the development of children, the large study from Tuovinen and colleagues clearly shows that depression during pregnancy can have negative effects on the child’s development, predicting lower scores on measures… Read More »
Research of the Week The latest MDMA trial finds it’s 76% effective at treating PTSD. Full FDA approval expected by 2021. As many as 500,000 years ago, Arabia was green, and hominids were living and traveling through there. Scare yourself to recalibrate your emotions. Increased frequency of global travel may actually reduce the danger of global… Read More »
Uguz and colleagues present data that indicate, in a group of women with panic disorder, neonatal outcomes were worse in the women who did not get treatment. This week’s roundup also features a lot of articles on postpartum depression, addressing an array of factors which increase women’s vulnerability to postpartum psychiatric illness, including adverse life… Read More »
This week, we have some data from our National Pregnancy Registry of Psychiatric Medications looking at infants exposed to quetiapine (Seroquel). Consistent with other studies we have seen recently, there appears to be no increase in risk of major malformations. There is also an interesting paper from DiFlorio and colleagues which assesses risk for postpartum… Read More »